Results 211 to 220 of about 51,241 (251)

Recanalization after intravenous thrombolysis

Neurology, 2007
To evaluate the time course of major vessel recanalization under IV thrombolysis in relation to functional outcome in acute ischemic stroke.A total of 99 patients with an acute anterior circulation vessel occlusion who underwent IV thrombolysis were included. All patients had a standardized admission and follow-up procedure.
M T, Wunderlich, M, Goertler, T, Postert, E, Schmitt, G, Seidel, G, Gahn, C, Samii, E, Stolz   +7 more
openaire   +2 more sources

Off‐label intravenous thrombolysis in acute stroke

European Journal of Neurology, 2011
Background and purpose:  Therapy for stroke with intravenous tissue plasminogen activator (IV‐tPA) is hampered by tight licensing restrictions; some of them have been discussed in recent literature. We assessed the safety and effectiveness of off‐label IV‐tPA in the clinical settings.Methods:  Retrospective analysis of all the patients treated with IV ...
M, Guillan, A, Alonso-Canovas, J, Garcia-Caldentey, V, Sanchez-Gonzalez, I, Hernandez-Medrano, A, Defelipe-Mimbrera, M C, Matute, M A, Alonso-Arias, M, Alonso de Leciñana, J, Masjuan   +9 more
openaire   +2 more sources

Intravenous Thrombolysis and Coronary Revascularization Rates

JAMA: The Journal of the American Medical Association, 1991
To the Editor.— The impact of intravenous thrombolysis on the rates of short-term interventional procedures (cardiac catheterization, angioplasty, and bypass surgery) was addressed recently by Naylor and Jaglal 1 and, in an accompanying editorial, by Schlant.
openaire   +2 more sources

Intravenous Thrombolysis for Acute Ischemic Stroke

Journal of Vascular and Interventional Radiology, 2004
Intravenous recombinant tissue-type plasminogen activator (rtPA, alteplase) is the only drug approved for the treatment of acute ischemic stroke. It should be administered within 3 hours of stroke. There is additional evidence, however, that administration at later times, by means of other methods, is effective.
openaire   +2 more sources

Intravenous Thrombolysis and Anti-thrombotics

2016
Intravenous thrombolysis with recombinant tissue plasminogen activator (rtPA) has revolutionized acute ischemic stroke care in the last two decades. The NINDS stroke study was pivotal in this transformation and conclusively demonstrated meaningful clinical improvement when IV rtPA is administered in the first 3 h of symptom onset.
Mahesh P. Kate, Rajsrinivas Parthasarathy, Ashfaq Shuaib   +2 more
openaire   +1 more source

Intravenous Thrombolysis

2022
Matthew Maximillian Padrick, Wendy Brown, Patrick D. Lyden   +2 more
openaire   +1 more source

[Comparison of intravenous thrombolysis and intracoronary thrombolysis].

Presse medicale (Paris, France : 1983), 1988
Any comparison between intravenous and intracoronary thrombolysis must take into account such elements as the delays imposed by coronary arteriography, the extra cost of the procedure, etc., but ultimately the answer can only be provided by a controlled trial comparing the two approaches.
openaire   +1 more source

Intravenous Thrombolysis

2019
Vasudha Singhal, Jaya Wanchoo
openaire   +2 more sources

Intravenous tenecteplase compared with alteplase for acute ischaemic stroke in Canada (AcT): a pragmatic, multicentre, open-label, registry-linked, randomised, controlled, non-inferiority trial

Lancet, The, 2022
Dar Dowlatshahi, Thalia S Field, Michael D Hill   +2 more
exaly  

Intravenous Thrombolysis

European Heart Journal, 1985
openaire   +1 more source